La situaci\u00f3n europea de las drogas: Infograf\u00eda interactiva<\/title>\r\n <script src=\"https:\/\/cdn.tailwindcss.com\"><\/script>\r\n <script src=\"https:\/\/cdn.jsdelivr.net\/npm\/chart.js\"><\/script>\r\n <link rel=\"preconnect\" href=\"https:\/\/fonts.googleapis.com\">\r\n <link rel=\"preconnect\" href=\"https:\/\/fonts.gstatic.com\" crossorigin>\r\n <link href=\"https:\/\/fonts.googleapis.com\/css2?family=Inter:wght@400;600;700&display=swap\" rel=\"stylesheet\">\r\n <style>\r\n #drug-infographic-container body {\r\n font-family: 'Inter', sans-serif;\r\n }\r\n #drug-infographic-container .chart-container {\r\n position: relative;\r\n width: 100%;\r\n max-width: 600px;\r\n margin-left: auto;\r\n margin-right: auto;\r\n height: 350px;\r\n max-height: 400px;\r\n }\r\n @media (min-width: 768px) {\r\n #drug-infographic-container .chart-container {\r\n height: 400px;\r\n }\r\n }\r\n #drug-infographic-container .stat-card {\r\n background-color: #ffffff;\r\n border-radius: 0.75rem;\r\n padding: 1.5rem;\r\n box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1), 0 2px 4px -2px rgba(0, 0, 0, 0.1);\r\n text-align: center;\r\n border-left: 5px solid #005f73;\r\n }\r\n #drug-infographic-container .stat-number {\r\n font-size: 2.5rem;\r\n font-weight: 700;\r\n color: #001219;\r\n }\r\n #drug-infographic-container .stat-label {\r\n font-size: 1rem;\r\n color: #0a9396;\r\n margin-top: 0.5rem;\r\n }\r\n #drug-infographic-container .section-title {\r\n font-size: 2.25rem;\r\n font-weight: 700;\r\n color: #001219;\r\n margin-bottom: 1rem;\r\n border-bottom: 3px solid #94d2bd;\r\n padding-bottom: 0.5rem;\r\n }\r\n #drug-infographic-container .section-intro {\r\n font-size: 1.125rem;\r\n color: #4A5568;\r\n max-width: 48rem;\r\n margin: 0 auto 2rem auto;\r\n }\r\n #drug-infographic-container .card {\r\n background-color: white;\r\n border-radius: 0.75rem;\r\n box-shadow: 0 10px 15px -3px rgba(0, 0, 0, 0.1), 0 4px 6px -4px rgba(0, 0, 0, 0.1);\r\n padding: 1.5rem;\r\n height: 100%;\r\n display: flex;\r\n flex-direction: column;\r\n }\r\n #drug-infographic-container .card-title {\r\n font-size: 1.5rem;\r\n font-weight: 600;\r\n color: #005f73;\r\n margin-bottom: 1rem;\r\n }\r\n #drug-infographic-container .card-text {\r\n font-size: 1rem;\r\n color: #4A5568;\r\n flex-grow: 1;\r\n margin-bottom: 1rem;\r\n }\r\n <\/style>\r\n<\/head>\r\n<body class=\"bg-[#f0f4f8] text-gray-800\">\r\n\r\n<div id=\"drug-infographic-container\">\r\n <header class=\"bg-[#001219] text-white py-8 px-4 text-center\">\r\n <h1 class=\"text-4xl md:text-5xl font-bold mb-2 text-[#94d2bd]\">El panorama farmac\u00e9utico europeo evoluciona<\/h1>\r\n <p class=\"text-lg md:text-xl max-w-3xl mx-auto text-gray-300\">Un an\u00e1lisis de las cifras clave, las amenazas emergentes y los retos para la salud p\u00fablica basado en datos de 2024.<\/p>\r\n <\/header>\r\n\r\n <main class=\"container mx-auto p-4 md:p-8\">\r\n \r\n <section class=\"mb-16 text-center\">\r\n <h2 class=\"section-title\">Una situaci\u00f3n compleja y din\u00e1mica<\/h2>\r\n <p class=\"section-intro\">El panorama europeo de las drogas se define por la elevada disponibilidad de drogas establecidas junto con el aumento de nuevas y potentes sustancias psicoactivas (NSP). Esta din\u00e1mica plantea retos sin precedentes para la salud p\u00fablica y exige respuestas adaptables y contundentes en todo el continente.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 lg:grid-cols-4 gap-6\">\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">24M<\/div>\r\n <div class=\"stat-label\">Adultos consumieron cannabis el a\u00f1o pasado<\/div>\r\n <\/div>\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">419t<\/div>\r\n <div class=\"stat-label\">R\u00e9cord de incautaciones de coca\u00edna en 2023<\/div>\r\n <\/div>\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">>1,000<\/div>\r\n <div class=\"stat-label\">Nuevas sustancias psicoactivas controladas<\/div>\r\n <\/div>\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">7 de cada 10<\/div>\r\n <div class=\"stat-label\">Sobredosis mortales de opi\u00e1ceos<\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Panorama general del consumo de drogas ilegales<\/h2>\r\n <p class=\"section-intro text-center\">El cannabis sigue siendo la droga il\u00edcita m\u00e1s consumida por un margen significativo, pero los estimulantes y los opi\u00e1ceos presentan niveles de da\u00f1o desproporcionados. El consumo es m\u00e1s frecuente entre los adultos j\u00f3venes, aunque las consecuencias m\u00e1s graves suelen observarse en cohortes de mayor edad, predominantemente masculinas.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Consumo de drogas en el \u00faltimo a\u00f1o entre los adultos j\u00f3venes (15-34)<\/h3>\r\n <p class=\"card-text\">Este gr\u00e1fico ilustra la prevalencia del consumo de las principales sustancias il\u00edcitas entre los j\u00f3venes europeos de 15 a 34 a\u00f1os. Si bien el consumo de cannabis est\u00e1 muy extendido, el de estimulantes como la coca\u00edna y la MDMA tambi\u00e9n es significativo en este grupo demogr\u00e1fico, lo que pone de relieve las \u00e1reas clave para los esfuerzos de prevenci\u00f3n espec\u00edficos.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"youngAdultsPrevalenceChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Demanda de primer tratamiento<\/h3>\r\n <p class=\"card-text\">Este gr\u00e1fico muestra las principales razones por las que las personas inician un tratamiento por consumo de drogas por primera vez. El aumento de los Trastornos por Consumo de Cannabis (TCA) como causa principal es una tendencia cr\u00edtica para la salud p\u00fablica, que se\u00f1ala las consecuencias de los productos de alta potencia y el cambio en la percepci\u00f3n del riesgo.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"treatmentDemandChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Coca\u00edna: Un mercado en m\u00e1ximos hist\u00f3ricos<\/h2>\r\n <p class=\"section-intro text-center\">La disponibilidad de coca\u00edna en Europa nunca ha sido tan alta, impulsada por el aumento de la producci\u00f3n y el sofisticado tr\u00e1fico. Esta oleada no solo alimenta el aumento del consumo y los da\u00f1os para la salud, incluido el consumo de crack, sino tambi\u00e9n la delincuencia y la violencia relacionadas con las drogas en algunas regiones.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Incautaciones r\u00e9cord de coca\u00edna en la UE (toneladas)<\/h3>\r\n <p class=\"card-text\">El volumen de coca\u00edna incautada por los Estados miembros de la UE ha alcanzado niveles sin precedentes, aumentando por s\u00e9ptimo a\u00f1o consecutivo. Este gr\u00e1fico muestra el espectacular crecimiento del tr\u00e1fico, con un aumento de las incautaciones de 323 toneladas en 2022 a 419 toneladas en 2023.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"cocaineSeizuresChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">An\u00e1lisis de aguas residuales: Puntos calientes de coca\u00edna<\/h3>\r\n <p class=\"card-text\">Los datos de las aguas residuales proporcionan una medida objetiva del consumo de drogas. Este gr\u00e1fico muestra la evoluci\u00f3n de los residuos de coca\u00edna en las aguas residuales entre 2023 y 2024 en 72 ciudades europeas, lo que confirma un consumo elevado y creciente, sobre todo en Europa occidental y meridional.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"cocaineWastewaterChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Opi\u00e1ceos: Una amenaza potente y en evoluci\u00f3n<\/h2>\r\n <p class=\"section-intro text-center\">El mercado de los opi\u00e1ceos est\u00e1 experimentando una peligrosa transformaci\u00f3n. Mientras que la hero\u00edna sigue causando da\u00f1os importantes entre una poblaci\u00f3n de consumidores que envejece, el aumento de nuevos opioides sint\u00e9ticos muy potentes, especialmente los nitazenos, plantea una amenaza aguda y creciente de sobredosis mortales en toda Europa.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">La doble carga del tratamiento de los opi\u00e1ceos<\/h3>\r\n <p class=\"card-text\">Europa se enfrenta a una \"doble epidemia\": atender a largo plazo a una poblaci\u00f3n envejecida de consumidores tradicionales de hero\u00edna y responder al mismo tiempo a los graves peligros de los nuevos opi\u00e1ceos sint\u00e9ticos (NSO), como los nitazenos. Este gr\u00e1fico compara el gran n\u00famero de clientes en tratamiento a largo plazo con agonistas opi\u00e1ceos (TAO) con el fuerte aumento de los decomisos de potentes nitazenos.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"opioidTreatmentVsThreatChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Causas de las sobredosis mortales<\/h3>\r\n <p class=\"card-text\">Los opioides son las principales sustancias implicadas en las muertes relacionadas con las drogas. Esta visualizaci\u00f3n ilustra claramente la magnitud del problema: los opioides estaban presentes en 7 de cada 10 casos de sobredosis mortal en los que se dispon\u00eda de datos toxicol\u00f3gicos en 2023.<\/p>\r\n <div class=\"flex flex-col items-center justify-center h-full text-center mt-4\">\r\n <div class=\"text-8xl font-bold text-[#ae2012]\">70%<\/div>\r\n <div class=\"text-xl font-semibold text-[#005f73] mt-1\">de las sobredosis mortales son de opi\u00e1ceos<\/div>\r\n <div class=\"w-full max-w-sm bg-gray-200 rounded-full h-6 mt-6 flex overflow-hidden border border-gray-300\">\r\n <div class=\"bg-[#ae2012] h-full\" style=\"width: 70%;\"><\/div>\r\n <div class=\"bg-gray-300 h-full\" style=\"width: 30%;\"><\/div>\r\n <\/div>\r\n <div class=\"w-full max-w-sm flex justify-between text-sm mt-1 text-gray-600\">\r\n <span>Con opi\u00e1ceos<\/span>\r\n <span>Otro\/ninguno<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">El reto de las nuevas sustancias psicoactivas (NSP)<\/h2>\r\n <p class=\"section-intro text-center\">El mercado de las NSP es un objetivo en r\u00e1pida evoluci\u00f3n, con vol\u00famenes sin precedentes de sustancias incautadas, como las catinonas sint\u00e9ticas, y la aparici\u00f3n constante de nuevos compuestos. Esto crea un juego del \"gato y el rat\u00f3n\" para los reguladores y un riesgo importante para los usuarios, que pueden consumir sin saberlo sustancias qu\u00edmicas potentes y peligrosas.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Aumento de las incautaciones de catinona sint\u00e9tica (toneladas)<\/h3>\r\n <p class=\"card-text\">El mercado de las catinonas sint\u00e9ticas se est\u00e1 expandiendo r\u00e1pidamente, y las incautaciones muestran un crecimiento exponencial. De solo 4,5 toneladas en 2021, la cantidad incautada se dispar\u00f3 a al menos 37 toneladas en 2023, lo que indica una importaci\u00f3n masiva a granel y un mercado nacional en crecimiento.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"cathinoneSeizuresChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Diversidad de nuevas sustancias detectadas (2024)<\/h3>\r\n <p class=\"card-text\">Solo en 2024 se notificaron 47 nuevas sustancias por primera vez en Europa. Este gr\u00e1fico desglosa los tipos de nuevas drogas que aparecen, destacando el importante n\u00famero de nuevos cannabinoides sint\u00e9ticos, catinonas y potentes opioides nitaz\u00e9nicos que las autoridades est\u00e1n rastreando.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"npsDiversityChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n \r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Del tr\u00e1fico mundial a la producci\u00f3n nacional<\/h2>\r\n <p class=\"section-intro text-center\">La oferta europea de drogas es un complejo entramado de rutas de tr\u00e1fico internacional y creciente producci\u00f3n nacional. Mientras que los principales puertos de B\u00e9lgica, los Pa\u00edses Bajos y Espa\u00f1a siguen siendo puntos de entrada clave para la coca\u00edna, los laboratorios il\u00edcitos de la UE est\u00e1n produciendo grandes cantidades de drogas sint\u00e9ticas como MDMA y anfetaminas.<\/p>\r\n <div class=\"bg-white rounded-lg shadow-lg p-6 md:p-8\">\r\n <div class=\"grid grid-cols-1 md:grid-cols-3 gap-8 items-center\">\r\n <div class=\"text-center\">\r\n <h4 class=\"text-xl font-bold text-[#005f73] mb-2\">Tr\u00e1fico en Sudam\u00e9rica<\/h4>\r\n <p class=\"text-6xl mb-2\">\ud83c\udf0e \u27a1\ufe0f \ud83d\udea2<\/p>\r\n <p>El aumento de la producci\u00f3n de coca en Sudam\u00e9rica alimenta los env\u00edos masivos de coca\u00edna a los principales puertos europeos (por ejemplo, Amberes, Rotterdam, puertos espa\u00f1oles).<\/p>\r\n <div class=\"mt-4 font-semibold text-lg bg-red-100 text-red-800 p-2 rounded\">Amenaza: Incautaci\u00f3n r\u00e9cord de 419 toneladas de coca\u00edna.<\/div>\r\n <\/div>\r\n \r\n <div class=\"text-gray-400 text-5xl font-bold text-center\">\r\n <span class=\"hidden md:block\">\u27a1\ufe0f<\/span>\r\n <span class=\"block md:hidden my-4\">\u2b07\ufe0f<\/span>\r\n <\/div>\r\n\r\n <div class=\"text-center\">\r\n <h4 class=\"text-xl font-bold text-[#005f73] mb-2\">Producci\u00f3n de drogas sint\u00e9ticas en la UE<\/h4>\r\n <p class=\"text-6xl mb-2\">\ud83c\udfed \ud83e\uddea \ud83d\ude9a<\/p>\r\n <p>Laboratorios situados principalmente en los Pa\u00edses Bajos, B\u00e9lgica, Polonia y Chequia producen grandes cantidades de MDMA, anfetaminas y catinonas para el mercado europeo.<\/p>\r\n <div class=\"mt-4 font-semibold text-lg bg-yellow-100 text-yellow-800 p-2 rounded\">Preocupaci\u00f3n: 36 laboratorios de MDMA y 93 de anfetaminas desmantelados en 2023.<\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <\/main>\r\n\r\n <footer class=\"bg-[#001219] text-white text-center p-6 mt-8\">\r\n <p>Esta infograf\u00eda se basa principalmente en datos del Observatorio Europeo de las Drogas y las Toxicoman\u00edas (OEDT) para 2023-2024.<\/p>\r\n <p class=\"text-sm text-gray-400 mt-2\">Dise\u00f1ado para proporcionar una visi\u00f3n general de alto nivel de una situaci\u00f3n compleja y en evoluci\u00f3n.<\/p>\r\n <\/footer>\r\n<\/div>\r\n\r\n<script>\r\n const initializeDrugInfographicCharts = () => {\r\n \/\/ A simple flag to prevent re-initialization, which can happen in some CMS environments\r\n if (window.drugChartInitialized) {\r\n return;\r\n }\r\n window.drugChartInitialized = true;\r\n\r\n const vibrantPalette = {\r\n blue: '#0a9396',\r\n teal: '#94d2bd',\r\n mint: '#e0fbfc',\r\n darkBlue: '#005f73',\r\n darkestBlue: '#001219',\r\n orange: '#ee9b00',\r\n red: '#ae2012',\r\n };\r\n\r\n const tooltipConfig = {\r\n plugins: {\r\n tooltip: {\r\n callbacks: {\r\n title: function(tooltipItems) {\r\n const item = tooltipItems[0];\r\n let label = item.chart.data.labels[item.dataIndex];\r\n if (Array.isArray(label)) {\r\n return label.join(' ');\r\n }\r\n return label;\r\n }\r\n }\r\n }\r\n }\r\n };\r\n\r\n function wrapLabel(str, maxWidth) {\r\n if (str.length <= maxWidth) return str;\r\n let words = str.split(' ');\r\n let lines = [];\r\n let currentLine = words[0];\r\n for (let i = 1; i < words.length; i++) {\r\n if ((currentLine.length + words[i].length + 1) < maxWidth) {\r\n currentLine += ' ' + words[i];\r\n } else {\r\n lines.push(currentLine);\r\n currentLine = words[i];\r\n }\r\n }\r\n lines.push(currentLine);\r\n return lines;\r\n }\r\n\r\n try {\r\n new Chart(document.getElementById('youngAdultsPrevalenceChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: ['Cannabis', 'Cocaine', 'MDMA', 'Amphetamines'],\r\n datasets: [{\r\n label: 'Last-Year Use (%)',\r\n data: [15.4, 2.6, 2.6, 1.6],\r\n backgroundColor: [vibrantPalette.blue, vibrantPalette.teal, vibrantPalette.orange, vibrantPalette.red],\r\n borderColor: vibrantPalette.darkestBlue,\r\n borderWidth: 1\r\n }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Prevalence (%)' } } }, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating youngAdultsPrevalenceChart:\", e); }\r\n \r\n try {\r\n new Chart(document.getElementById('treatmentDemandChart'), {\r\n type: 'doughnut',\r\n data: {\r\n labels: [ wrapLabel('Cannabis Use Disorder', 16), 'Opioids', 'Cocaine', 'Other' ],\r\n datasets: [{ data: [34, 23, 20, 23], backgroundColor: [vibrantPalette.blue, vibrantPalette.red, vibrantPalette.orange, vibrantPalette.teal], hoverOffset: 4 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating treatmentDemandChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('cocaineSeizuresChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: ['2021', '2022', '2023'],\r\n datasets: [{ label: 'Tonnes Seized', data: [222, 323, 419], backgroundColor: vibrantPalette.orange, borderColor: vibrantPalette.darkestBlue, borderWidth: 1 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Quantity in Tonnes' } } }, plugins: { ...tooltipConfig.plugins, legend: { display: false } } }\r\n });\r\n } catch(e) { console.error(\"Error creating cocaineSeizuresChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('cocaineWastewaterChart'), {\r\n type: 'pie',\r\n data: {\r\n labels: ['Increase in Residues', 'No Change', 'Decrease'],\r\n datasets: [{ label: 'Cities (Total 72)', data: [39, 17, 16], backgroundColor: [vibrantPalette.red, vibrantPalette.teal, vibrantPalette.blue], hoverOffset: 4 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating cocaineWastewaterChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('opioidTreatmentVsThreatChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: [wrapLabel('Clients in Opioid Agonist Treatment', 16), wrapLabel('Nitazenes Seized (kg)', 16)],\r\n datasets: [ { label: '2022', data: [510000, 3], backgroundColor: vibrantPalette.teal, }, { label: '2023', data: [511000, 10], backgroundColor: vibrantPalette.blue, } ]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { type: 'logarithmic', beginAtZero: true, title: { display: true, text: 'Count \/ Kilograms (Log Scale)' } } }, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating opioidTreatmentVsThreatChart:\", e); }\r\n \r\n try {\r\n new Chart(document.getElementById('cathinoneSeizuresChart'), {\r\n type: 'line',\r\n data: {\r\n labels: ['2021', '2022', '2023'],\r\n datasets: [{ label: 'Tonnes Seized', data: [4.5, 27, 37], fill: true, borderColor: vibrantPalette.red, backgroundColor: 'rgba(174, 32, 18, 0.2)', tension: 0.1 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Quantity in Tonnes' } } }, plugins: { ...tooltipConfig.plugins, legend: { display: false } } }\r\n });\r\n } catch(e) { console.error(\"Error creating cathinoneSeizuresChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('npsDiversityChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: [wrapLabel('New Cannabinoids*', 16), wrapLabel('New Cathinones', 16), wrapLabel('New Opioids (Nitazenes)', 16), 'Other NPS'],\r\n datasets: [{ label: 'New Substances Detected in 2024 (Total 47)', data: [15, 7, 7, 18], backgroundColor: [vibrantPalette.blue, vibrantPalette.orange, vibrantPalette.red, vibrantPalette.teal], }]\r\n },\r\n options: { indexAxis: 'y', responsive: true, maintainAspectRatio: false, scales: { x: { beginAtZero: true, title: { display: true, text: 'Number of New Substances' } } }, plugins: { ...tooltipConfig.plugins, legend: { display: false }, tooltip: { ...tooltipConfig.plugins.tooltip, footer: '*Cannabinoid data reflects 2022 reports as a recent high-water mark.' } } }\r\n });\r\n } catch(e) { console.error(\"Error creating npsDiversityChart:\", e); }\r\n };\r\n\r\n \/\/ This robustly waits for the DOM to be ready before trying to create the charts.\r\n if (document.readyState === 'loading') {\r\n document.addEventListener('DOMContentLoaded', initializeDrugInfographicCharts);\r\n } else {\r\n \/\/ DOMContentLoaded has already fired\r\n initializeDrugInfographicCharts();\r\n }\r\n<\/script>\r\n\r\n<\/body>\r\n<\/html>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>La situaci\u00f3n europea de las drogas: Una infograf\u00eda interactiva El panorama europeo de las drogas en evoluci\u00f3n Un an\u00e1lisis de las cifras clave, las amenazas emergentes [...]<\/p>","protected":false},"author":2,"featured_media":3816,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[4,35],"tags":[99,102,101,95,97,61,98,100],"class_list":["post-3813","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-addiction","category-drug-facts","tag-cocaine-trafficking-europe","tag-drug-crisis-europe","tag-drug-policy-eu","tag-drug-free-rehabilitation","tag-european-drug-trends","tag-narconon","tag-synthetic-drugs-europe","tag-youth-addiction-europe"],"acf":[],"yoast_head":"\n<title>Evolving Drug Landscape in Europe: Key Trends<\/title>\n<meta name=\"description\" content=\"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.narconon.online\/es\/evolucion-del-panorama-farmaceutico-europeo\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Europe's Evolving Drug Landscape\" \/>\n<meta property=\"og:description\" content=\"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.narconon.online\/es\/evolucion-del-panorama-farmaceutico-europeo\/\" \/>\n<meta property=\"og:site_name\" content=\"Narconon Europe\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/narcononeu\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-08T18:52:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-07T08:30:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"896\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Jacky Buensoz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NARCONONEurope\" \/>\n<meta name=\"twitter:site\" content=\"@NARCONONEurope\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jacky Buensoz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\"},\"author\":{\"name\":\"Jacky Buensoz\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46\"},\"headline\":\"Europe’s Evolving Drug Landscape\",\"datePublished\":\"2025-06-08T18:52:34+00:00\",\"dateModified\":\"2025-07-07T08:30:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\"},\"wordCount\":792,\"publisher\":{\"@id\":\"https:\/\/www.narconon.online\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"keywords\":[\"Cocaine trafficking Europe\",\"Drug crisis Europe\",\"Drug policy EU\",\"Drug-free rehabilitation\",\"European drug trends\",\"Narconon\",\"Synthetic drugs Europe\",\"Youth addiction Europe\"],\"articleSection\":[\"Addiction\",\"Drug Facts\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\",\"url\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\",\"name\":\"Evolving Drug Landscape in Europe: Key Trends\",\"isPartOf\":{\"@id\":\"https:\/\/www.narconon.online\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"datePublished\":\"2025-06-08T18:52:34+00:00\",\"dateModified\":\"2025-07-07T08:30:27+00:00\",\"description\":\"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\",\"url\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"contentUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"width\":1280,\"height\":896,\"caption\":\"Visual representation of the evolving drug landscape in Europe, showing shifting trends and emerging synthetic substances\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.narconon.online\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Europe’s Evolving Drug Landscape\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.narconon.online\/#website\",\"url\":\"https:\/\/www.narconon.online\/\",\"name\":\"Narconon Europe\",\"description\":\"Drug Free For Good\",\"publisher\":{\"@id\":\"https:\/\/www.narconon.online\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.narconon.online\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.narconon.online\/#organization\",\"name\":\"Narconon Europe\",\"url\":\"https:\/\/www.narconon.online\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png\",\"contentUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png\",\"width\":2000,\"height\":707,\"caption\":\"Narconon Europe\"},\"image\":{\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/narcononeu\",\"https:\/\/x.com\/NARCONONEurope\",\"https:\/\/www.instagram.com\/narconon.europe\/\",\"https:\/\/www.youtube.com\/channel\/UCNUxvhoqZZCAxXCYO4K7MvA\",\"https:\/\/www.tiktok.com\/@narconon.europe\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46\",\"name\":\"Jacky Buensoz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g\",\"caption\":\"Jacky Buensoz\"},\"description\":\"I have personally experienced various drugs before making the life-changing decision to turn things around. In 1993, I completed the Narconon program in Plans-sur-Bex, Switzerland, a pivotal experience that set me on a new path. Since then, I have dedicated my life to helping and rehabilitating addicts, gaining decades of experience in prevention, rehabilitation, and family support. With years of hands-on experience, I have been serving as the Director of Narconon Europe for the past four years. My mission is to provide effective solutions to help those struggling with addiction and to support their loved ones throughout this transformative journey. My goal is to bring about real change, sharing my expertise and guiding individuals toward a life free from addiction.\"}]}<\/script>\n","yoast_head_json":{"title":"Evoluci\u00f3n del panorama farmac\u00e9utico en Europa: Tendencias clave","description":"Explore la evoluci\u00f3n del panorama farmac\u00e9utico en Europa con datos de 2024 sobre amenazas emergentes y retos para la salud p\u00fablica.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.narconon.online\/es\/evolucion-del-panorama-farmaceutico-europeo\/","og_locale":"es_ES","og_type":"article","og_title":"Europe's Evolving Drug Landscape","og_description":"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.","og_url":"https:\/\/www.narconon.online\/es\/evolucion-del-panorama-farmaceutico-europeo\/","og_site_name":"Narconon Europe","article_publisher":"https:\/\/www.facebook.com\/narcononeu","article_published_time":"2025-06-08T18:52:34+00:00","article_modified_time":"2025-07-07T08:30:27+00:00","og_image":[{"width":1280,"height":896,"url":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","type":"image\/webp"}],"author":"Jacky Buensoz","twitter_card":"summary_large_image","twitter_creator":"@NARCONONEurope","twitter_site":"@NARCONONEurope","twitter_misc":{"Escrito por":"Jacky Buensoz","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#article","isPartOf":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/"},"author":{"name":"Jacky Buensoz","@id":"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46"},"headline":"Europe’s Evolving Drug Landscape","datePublished":"2025-06-08T18:52:34+00:00","dateModified":"2025-07-07T08:30:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/"},"wordCount":792,"publisher":{"@id":"https:\/\/www.narconon.online\/#organization"},"image":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage"},"thumbnailUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","keywords":["Cocaine trafficking Europe","Drug crisis Europe","Drug policy EU","Drug-free rehabilitation","European drug trends","Narconon","Synthetic drugs Europe","Youth addiction Europe"],"articleSection":["Addiction","Drug Facts"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/","url":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/","name":"Evoluci\u00f3n del panorama farmac\u00e9utico en Europa: Tendencias clave","isPartOf":{"@id":"https:\/\/www.narconon.online\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage"},"image":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage"},"thumbnailUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","datePublished":"2025-06-08T18:52:34+00:00","dateModified":"2025-07-07T08:30:27+00:00","description":"Explore la evoluci\u00f3n del panorama farmac\u00e9utico en Europa con datos de 2024 sobre amenazas emergentes y retos para la salud p\u00fablica.","breadcrumb":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage","url":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","contentUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","width":1280,"height":896,"caption":"Visual representation of the evolving drug landscape in Europe, showing shifting trends and emerging synthetic substances"},{"@type":"BreadcrumbList","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.narconon.online\/"},{"@type":"ListItem","position":2,"name":"Europe’s Evolving Drug Landscape"}]},{"@type":"WebSite","@id":"https:\/\/www.narconon.online\/#website","url":"https:\/\/www.narconon.online\/","name":"Narconon Europa","description":"Libre de drogas para siempre","publisher":{"@id":"https:\/\/www.narconon.online\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.narconon.online\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.narconon.online\/#organization","name":"Narconon Europa","url":"https:\/\/www.narconon.online\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/","url":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png","contentUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png","width":2000,"height":707,"caption":"Narconon Europe"},"image":{"@id":"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/narcononeu","https:\/\/x.com\/NARCONONEurope","https:\/\/www.instagram.com\/narconon.europe\/","https:\/\/www.youtube.com\/channel\/UCNUxvhoqZZCAxXCYO4K7MvA","https:\/\/www.tiktok.com\/@narconon.europe"]},{"@type":"Person","@id":"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46","name":"Jacky Buensoz","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.narconon.online\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g","caption":"Jacky Buensoz"},"description":"He experimentado personalmente varias drogas antes de tomar la decisi\u00f3n de cambiar mi vida. En 1993, complet\u00e9 el programa Narconon en Plans-sur-Bex, Suiza, una experiencia crucial que me marc\u00f3 un nuevo camino. Desde entonces, he dedicado mi vida a ayudar y rehabilitar a adictos, adquiriendo d\u00e9cadas de experiencia en prevenci\u00f3n, rehabilitaci\u00f3n y apoyo familiar. Con a\u00f1os de experiencia pr\u00e1ctica, he sido Director de Narconon Europa durante los \u00faltimos cuatro a\u00f1os. Mi misi\u00f3n es proporcionar soluciones eficaces para ayudar a aquellos que luchan contra la adicci\u00f3n y apoyar a sus seres queridos a lo largo de este viaje transformador. Mi objetivo es lograr un cambio real, compartiendo mi experiencia y guiando a las personas hacia una vida libre de adicciones."}]}},"_links":{"self":[{"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/posts\/3813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/comments?post=3813"}],"version-history":[{"count":20,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/posts\/3813\/revisions"}],"predecessor-version":[{"id":3845,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/posts\/3813\/revisions\/3845"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/media\/3816"}],"wp:attachment":[{"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/media?parent=3813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/categories?post=3813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/tags?post=3813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

\n\t\t\t\t

\n\t\t\t\t\t

\n\t\t\t\t

\n\t\t\t\t\t\r\n\r\n\r\n \r\n \r\n La situaci\u00f3n europea de las drogas: Infograf\u00eda interactiva<\/title>\r\n <script src=\"https:\/\/cdn.tailwindcss.com\"><\/script>\r\n <script src=\"https:\/\/cdn.jsdelivr.net\/npm\/chart.js\"><\/script>\r\n <link rel=\"preconnect\" href=\"https:\/\/fonts.googleapis.com\">\r\n <link rel=\"preconnect\" href=\"https:\/\/fonts.gstatic.com\" crossorigin>\r\n <link href=\"https:\/\/fonts.googleapis.com\/css2?family=Inter:wght@400;600;700&display=swap\" rel=\"stylesheet\">\r\n <style>\r\n #drug-infographic-container body {\r\n font-family: 'Inter', sans-serif;\r\n }\r\n #drug-infographic-container .chart-container {\r\n position: relative;\r\n width: 100%;\r\n max-width: 600px;\r\n margin-left: auto;\r\n margin-right: auto;\r\n height: 350px;\r\n max-height: 400px;\r\n }\r\n @media (min-width: 768px) {\r\n #drug-infographic-container .chart-container {\r\n height: 400px;\r\n }\r\n }\r\n #drug-infographic-container .stat-card {\r\n background-color: #ffffff;\r\n border-radius: 0.75rem;\r\n padding: 1.5rem;\r\n box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1), 0 2px 4px -2px rgba(0, 0, 0, 0.1);\r\n text-align: center;\r\n border-left: 5px solid #005f73;\r\n }\r\n #drug-infographic-container .stat-number {\r\n font-size: 2.5rem;\r\n font-weight: 700;\r\n color: #001219;\r\n }\r\n #drug-infographic-container .stat-label {\r\n font-size: 1rem;\r\n color: #0a9396;\r\n margin-top: 0.5rem;\r\n }\r\n #drug-infographic-container .section-title {\r\n font-size: 2.25rem;\r\n font-weight: 700;\r\n color: #001219;\r\n margin-bottom: 1rem;\r\n border-bottom: 3px solid #94d2bd;\r\n padding-bottom: 0.5rem;\r\n }\r\n #drug-infographic-container .section-intro {\r\n font-size: 1.125rem;\r\n color: #4A5568;\r\n max-width: 48rem;\r\n margin: 0 auto 2rem auto;\r\n }\r\n #drug-infographic-container .card {\r\n background-color: white;\r\n border-radius: 0.75rem;\r\n box-shadow: 0 10px 15px -3px rgba(0, 0, 0, 0.1), 0 4px 6px -4px rgba(0, 0, 0, 0.1);\r\n padding: 1.5rem;\r\n height: 100%;\r\n display: flex;\r\n flex-direction: column;\r\n }\r\n #drug-infographic-container .card-title {\r\n font-size: 1.5rem;\r\n font-weight: 600;\r\n color: #005f73;\r\n margin-bottom: 1rem;\r\n }\r\n #drug-infographic-container .card-text {\r\n font-size: 1rem;\r\n color: #4A5568;\r\n flex-grow: 1;\r\n margin-bottom: 1rem;\r\n }\r\n <\/style>\r\n<\/head>\r\n<body class=\"bg-[#f0f4f8] text-gray-800\">\r\n\r\n<div id=\"drug-infographic-container\">\r\n <header class=\"bg-[#001219] text-white py-8 px-4 text-center\">\r\n <h1 class=\"text-4xl md:text-5xl font-bold mb-2 text-[#94d2bd]\">El panorama farmac\u00e9utico europeo evoluciona<\/h1>\r\n <p class=\"text-lg md:text-xl max-w-3xl mx-auto text-gray-300\">Un an\u00e1lisis de las cifras clave, las amenazas emergentes y los retos para la salud p\u00fablica basado en datos de 2024.<\/p>\r\n <\/header>\r\n\r\n <main class=\"container mx-auto p-4 md:p-8\">\r\n \r\n <section class=\"mb-16 text-center\">\r\n <h2 class=\"section-title\">Una situaci\u00f3n compleja y din\u00e1mica<\/h2>\r\n <p class=\"section-intro\">El panorama europeo de las drogas se define por la elevada disponibilidad de drogas establecidas junto con el aumento de nuevas y potentes sustancias psicoactivas (NSP). Esta din\u00e1mica plantea retos sin precedentes para la salud p\u00fablica y exige respuestas adaptables y contundentes en todo el continente.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 lg:grid-cols-4 gap-6\">\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">24M<\/div>\r\n <div class=\"stat-label\">Adultos consumieron cannabis el a\u00f1o pasado<\/div>\r\n <\/div>\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">419t<\/div>\r\n <div class=\"stat-label\">R\u00e9cord de incautaciones de coca\u00edna en 2023<\/div>\r\n <\/div>\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">>1,000<\/div>\r\n <div class=\"stat-label\">Nuevas sustancias psicoactivas controladas<\/div>\r\n <\/div>\r\n <div class=\"stat-card\">\r\n <div class=\"stat-number\">7 de cada 10<\/div>\r\n <div class=\"stat-label\">Sobredosis mortales de opi\u00e1ceos<\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Panorama general del consumo de drogas ilegales<\/h2>\r\n <p class=\"section-intro text-center\">El cannabis sigue siendo la droga il\u00edcita m\u00e1s consumida por un margen significativo, pero los estimulantes y los opi\u00e1ceos presentan niveles de da\u00f1o desproporcionados. El consumo es m\u00e1s frecuente entre los adultos j\u00f3venes, aunque las consecuencias m\u00e1s graves suelen observarse en cohortes de mayor edad, predominantemente masculinas.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Consumo de drogas en el \u00faltimo a\u00f1o entre los adultos j\u00f3venes (15-34)<\/h3>\r\n <p class=\"card-text\">Este gr\u00e1fico ilustra la prevalencia del consumo de las principales sustancias il\u00edcitas entre los j\u00f3venes europeos de 15 a 34 a\u00f1os. Si bien el consumo de cannabis est\u00e1 muy extendido, el de estimulantes como la coca\u00edna y la MDMA tambi\u00e9n es significativo en este grupo demogr\u00e1fico, lo que pone de relieve las \u00e1reas clave para los esfuerzos de prevenci\u00f3n espec\u00edficos.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"youngAdultsPrevalenceChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Demanda de primer tratamiento<\/h3>\r\n <p class=\"card-text\">Este gr\u00e1fico muestra las principales razones por las que las personas inician un tratamiento por consumo de drogas por primera vez. El aumento de los Trastornos por Consumo de Cannabis (TCA) como causa principal es una tendencia cr\u00edtica para la salud p\u00fablica, que se\u00f1ala las consecuencias de los productos de alta potencia y el cambio en la percepci\u00f3n del riesgo.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"treatmentDemandChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Coca\u00edna: Un mercado en m\u00e1ximos hist\u00f3ricos<\/h2>\r\n <p class=\"section-intro text-center\">La disponibilidad de coca\u00edna en Europa nunca ha sido tan alta, impulsada por el aumento de la producci\u00f3n y el sofisticado tr\u00e1fico. Esta oleada no solo alimenta el aumento del consumo y los da\u00f1os para la salud, incluido el consumo de crack, sino tambi\u00e9n la delincuencia y la violencia relacionadas con las drogas en algunas regiones.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Incautaciones r\u00e9cord de coca\u00edna en la UE (toneladas)<\/h3>\r\n <p class=\"card-text\">El volumen de coca\u00edna incautada por los Estados miembros de la UE ha alcanzado niveles sin precedentes, aumentando por s\u00e9ptimo a\u00f1o consecutivo. Este gr\u00e1fico muestra el espectacular crecimiento del tr\u00e1fico, con un aumento de las incautaciones de 323 toneladas en 2022 a 419 toneladas en 2023.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"cocaineSeizuresChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">An\u00e1lisis de aguas residuales: Puntos calientes de coca\u00edna<\/h3>\r\n <p class=\"card-text\">Los datos de las aguas residuales proporcionan una medida objetiva del consumo de drogas. Este gr\u00e1fico muestra la evoluci\u00f3n de los residuos de coca\u00edna en las aguas residuales entre 2023 y 2024 en 72 ciudades europeas, lo que confirma un consumo elevado y creciente, sobre todo en Europa occidental y meridional.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"cocaineWastewaterChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Opi\u00e1ceos: Una amenaza potente y en evoluci\u00f3n<\/h2>\r\n <p class=\"section-intro text-center\">El mercado de los opi\u00e1ceos est\u00e1 experimentando una peligrosa transformaci\u00f3n. Mientras que la hero\u00edna sigue causando da\u00f1os importantes entre una poblaci\u00f3n de consumidores que envejece, el aumento de nuevos opioides sint\u00e9ticos muy potentes, especialmente los nitazenos, plantea una amenaza aguda y creciente de sobredosis mortales en toda Europa.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">La doble carga del tratamiento de los opi\u00e1ceos<\/h3>\r\n <p class=\"card-text\">Europa se enfrenta a una \"doble epidemia\": atender a largo plazo a una poblaci\u00f3n envejecida de consumidores tradicionales de hero\u00edna y responder al mismo tiempo a los graves peligros de los nuevos opi\u00e1ceos sint\u00e9ticos (NSO), como los nitazenos. Este gr\u00e1fico compara el gran n\u00famero de clientes en tratamiento a largo plazo con agonistas opi\u00e1ceos (TAO) con el fuerte aumento de los decomisos de potentes nitazenos.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"opioidTreatmentVsThreatChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Causas de las sobredosis mortales<\/h3>\r\n <p class=\"card-text\">Los opioides son las principales sustancias implicadas en las muertes relacionadas con las drogas. Esta visualizaci\u00f3n ilustra claramente la magnitud del problema: los opioides estaban presentes en 7 de cada 10 casos de sobredosis mortal en los que se dispon\u00eda de datos toxicol\u00f3gicos en 2023.<\/p>\r\n <div class=\"flex flex-col items-center justify-center h-full text-center mt-4\">\r\n <div class=\"text-8xl font-bold text-[#ae2012]\">70%<\/div>\r\n <div class=\"text-xl font-semibold text-[#005f73] mt-1\">de las sobredosis mortales son de opi\u00e1ceos<\/div>\r\n <div class=\"w-full max-w-sm bg-gray-200 rounded-full h-6 mt-6 flex overflow-hidden border border-gray-300\">\r\n <div class=\"bg-[#ae2012] h-full\" style=\"width: 70%;\"><\/div>\r\n <div class=\"bg-gray-300 h-full\" style=\"width: 30%;\"><\/div>\r\n <\/div>\r\n <div class=\"w-full max-w-sm flex justify-between text-sm mt-1 text-gray-600\">\r\n <span>Con opi\u00e1ceos<\/span>\r\n <span>Otro\/ninguno<\/span>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">El reto de las nuevas sustancias psicoactivas (NSP)<\/h2>\r\n <p class=\"section-intro text-center\">El mercado de las NSP es un objetivo en r\u00e1pida evoluci\u00f3n, con vol\u00famenes sin precedentes de sustancias incautadas, como las catinonas sint\u00e9ticas, y la aparici\u00f3n constante de nuevos compuestos. Esto crea un juego del \"gato y el rat\u00f3n\" para los reguladores y un riesgo importante para los usuarios, que pueden consumir sin saberlo sustancias qu\u00edmicas potentes y peligrosas.<\/p>\r\n <div class=\"grid grid-cols-1 md:grid-cols-2 gap-8 items-stretch\">\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Aumento de las incautaciones de catinona sint\u00e9tica (toneladas)<\/h3>\r\n <p class=\"card-text\">El mercado de las catinonas sint\u00e9ticas se est\u00e1 expandiendo r\u00e1pidamente, y las incautaciones muestran un crecimiento exponencial. De solo 4,5 toneladas en 2021, la cantidad incautada se dispar\u00f3 a al menos 37 toneladas en 2023, lo que indica una importaci\u00f3n masiva a granel y un mercado nacional en crecimiento.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"cathinoneSeizuresChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <div class=\"card\">\r\n <h3 class=\"card-title\">Diversidad de nuevas sustancias detectadas (2024)<\/h3>\r\n <p class=\"card-text\">Solo en 2024 se notificaron 47 nuevas sustancias por primera vez en Europa. Este gr\u00e1fico desglosa los tipos de nuevas drogas que aparecen, destacando el importante n\u00famero de nuevos cannabinoides sint\u00e9ticos, catinonas y potentes opioides nitaz\u00e9nicos que las autoridades est\u00e1n rastreando.<\/p>\r\n <div class=\"chart-container\">\r\n <canvas id=\"npsDiversityChart\"><\/canvas>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n \r\n <section class=\"mb-16\">\r\n <h2 class=\"section-title text-center\">Del tr\u00e1fico mundial a la producci\u00f3n nacional<\/h2>\r\n <p class=\"section-intro text-center\">La oferta europea de drogas es un complejo entramado de rutas de tr\u00e1fico internacional y creciente producci\u00f3n nacional. Mientras que los principales puertos de B\u00e9lgica, los Pa\u00edses Bajos y Espa\u00f1a siguen siendo puntos de entrada clave para la coca\u00edna, los laboratorios il\u00edcitos de la UE est\u00e1n produciendo grandes cantidades de drogas sint\u00e9ticas como MDMA y anfetaminas.<\/p>\r\n <div class=\"bg-white rounded-lg shadow-lg p-6 md:p-8\">\r\n <div class=\"grid grid-cols-1 md:grid-cols-3 gap-8 items-center\">\r\n <div class=\"text-center\">\r\n <h4 class=\"text-xl font-bold text-[#005f73] mb-2\">Tr\u00e1fico en Sudam\u00e9rica<\/h4>\r\n <p class=\"text-6xl mb-2\">\ud83c\udf0e \u27a1\ufe0f \ud83d\udea2<\/p>\r\n <p>El aumento de la producci\u00f3n de coca en Sudam\u00e9rica alimenta los env\u00edos masivos de coca\u00edna a los principales puertos europeos (por ejemplo, Amberes, Rotterdam, puertos espa\u00f1oles).<\/p>\r\n <div class=\"mt-4 font-semibold text-lg bg-red-100 text-red-800 p-2 rounded\">Amenaza: Incautaci\u00f3n r\u00e9cord de 419 toneladas de coca\u00edna.<\/div>\r\n <\/div>\r\n \r\n <div class=\"text-gray-400 text-5xl font-bold text-center\">\r\n <span class=\"hidden md:block\">\u27a1\ufe0f<\/span>\r\n <span class=\"block md:hidden my-4\">\u2b07\ufe0f<\/span>\r\n <\/div>\r\n\r\n <div class=\"text-center\">\r\n <h4 class=\"text-xl font-bold text-[#005f73] mb-2\">Producci\u00f3n de drogas sint\u00e9ticas en la UE<\/h4>\r\n <p class=\"text-6xl mb-2\">\ud83c\udfed \ud83e\uddea \ud83d\ude9a<\/p>\r\n <p>Laboratorios situados principalmente en los Pa\u00edses Bajos, B\u00e9lgica, Polonia y Chequia producen grandes cantidades de MDMA, anfetaminas y catinonas para el mercado europeo.<\/p>\r\n <div class=\"mt-4 font-semibold text-lg bg-yellow-100 text-yellow-800 p-2 rounded\">Preocupaci\u00f3n: 36 laboratorios de MDMA y 93 de anfetaminas desmantelados en 2023.<\/div>\r\n <\/div>\r\n <\/div>\r\n <\/div>\r\n <\/section>\r\n\r\n <\/main>\r\n\r\n <footer class=\"bg-[#001219] text-white text-center p-6 mt-8\">\r\n <p>Esta infograf\u00eda se basa principalmente en datos del Observatorio Europeo de las Drogas y las Toxicoman\u00edas (OEDT) para 2023-2024.<\/p>\r\n <p class=\"text-sm text-gray-400 mt-2\">Dise\u00f1ado para proporcionar una visi\u00f3n general de alto nivel de una situaci\u00f3n compleja y en evoluci\u00f3n.<\/p>\r\n <\/footer>\r\n<\/div>\r\n\r\n<script>\r\n const initializeDrugInfographicCharts = () => {\r\n \/\/ A simple flag to prevent re-initialization, which can happen in some CMS environments\r\n if (window.drugChartInitialized) {\r\n return;\r\n }\r\n window.drugChartInitialized = true;\r\n\r\n const vibrantPalette = {\r\n blue: '#0a9396',\r\n teal: '#94d2bd',\r\n mint: '#e0fbfc',\r\n darkBlue: '#005f73',\r\n darkestBlue: '#001219',\r\n orange: '#ee9b00',\r\n red: '#ae2012',\r\n };\r\n\r\n const tooltipConfig = {\r\n plugins: {\r\n tooltip: {\r\n callbacks: {\r\n title: function(tooltipItems) {\r\n const item = tooltipItems[0];\r\n let label = item.chart.data.labels[item.dataIndex];\r\n if (Array.isArray(label)) {\r\n return label.join(' ');\r\n }\r\n return label;\r\n }\r\n }\r\n }\r\n }\r\n };\r\n\r\n function wrapLabel(str, maxWidth) {\r\n if (str.length <= maxWidth) return str;\r\n let words = str.split(' ');\r\n let lines = [];\r\n let currentLine = words[0];\r\n for (let i = 1; i < words.length; i++) {\r\n if ((currentLine.length + words[i].length + 1) < maxWidth) {\r\n currentLine += ' ' + words[i];\r\n } else {\r\n lines.push(currentLine);\r\n currentLine = words[i];\r\n }\r\n }\r\n lines.push(currentLine);\r\n return lines;\r\n }\r\n\r\n try {\r\n new Chart(document.getElementById('youngAdultsPrevalenceChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: ['Cannabis', 'Cocaine', 'MDMA', 'Amphetamines'],\r\n datasets: [{\r\n label: 'Last-Year Use (%)',\r\n data: [15.4, 2.6, 2.6, 1.6],\r\n backgroundColor: [vibrantPalette.blue, vibrantPalette.teal, vibrantPalette.orange, vibrantPalette.red],\r\n borderColor: vibrantPalette.darkestBlue,\r\n borderWidth: 1\r\n }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Prevalence (%)' } } }, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating youngAdultsPrevalenceChart:\", e); }\r\n \r\n try {\r\n new Chart(document.getElementById('treatmentDemandChart'), {\r\n type: 'doughnut',\r\n data: {\r\n labels: [ wrapLabel('Cannabis Use Disorder', 16), 'Opioids', 'Cocaine', 'Other' ],\r\n datasets: [{ data: [34, 23, 20, 23], backgroundColor: [vibrantPalette.blue, vibrantPalette.red, vibrantPalette.orange, vibrantPalette.teal], hoverOffset: 4 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating treatmentDemandChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('cocaineSeizuresChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: ['2021', '2022', '2023'],\r\n datasets: [{ label: 'Tonnes Seized', data: [222, 323, 419], backgroundColor: vibrantPalette.orange, borderColor: vibrantPalette.darkestBlue, borderWidth: 1 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Quantity in Tonnes' } } }, plugins: { ...tooltipConfig.plugins, legend: { display: false } } }\r\n });\r\n } catch(e) { console.error(\"Error creating cocaineSeizuresChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('cocaineWastewaterChart'), {\r\n type: 'pie',\r\n data: {\r\n labels: ['Increase in Residues', 'No Change', 'Decrease'],\r\n datasets: [{ label: 'Cities (Total 72)', data: [39, 17, 16], backgroundColor: [vibrantPalette.red, vibrantPalette.teal, vibrantPalette.blue], hoverOffset: 4 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating cocaineWastewaterChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('opioidTreatmentVsThreatChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: [wrapLabel('Clients in Opioid Agonist Treatment', 16), wrapLabel('Nitazenes Seized (kg)', 16)],\r\n datasets: [ { label: '2022', data: [510000, 3], backgroundColor: vibrantPalette.teal, }, { label: '2023', data: [511000, 10], backgroundColor: vibrantPalette.blue, } ]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { type: 'logarithmic', beginAtZero: true, title: { display: true, text: 'Count \/ Kilograms (Log Scale)' } } }, plugins: tooltipConfig.plugins }\r\n });\r\n } catch(e) { console.error(\"Error creating opioidTreatmentVsThreatChart:\", e); }\r\n \r\n try {\r\n new Chart(document.getElementById('cathinoneSeizuresChart'), {\r\n type: 'line',\r\n data: {\r\n labels: ['2021', '2022', '2023'],\r\n datasets: [{ label: 'Tonnes Seized', data: [4.5, 27, 37], fill: true, borderColor: vibrantPalette.red, backgroundColor: 'rgba(174, 32, 18, 0.2)', tension: 0.1 }]\r\n },\r\n options: { responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: 'Quantity in Tonnes' } } }, plugins: { ...tooltipConfig.plugins, legend: { display: false } } }\r\n });\r\n } catch(e) { console.error(\"Error creating cathinoneSeizuresChart:\", e); }\r\n\r\n try {\r\n new Chart(document.getElementById('npsDiversityChart'), {\r\n type: 'bar',\r\n data: {\r\n labels: [wrapLabel('New Cannabinoids*', 16), wrapLabel('New Cathinones', 16), wrapLabel('New Opioids (Nitazenes)', 16), 'Other NPS'],\r\n datasets: [{ label: 'New Substances Detected in 2024 (Total 47)', data: [15, 7, 7, 18], backgroundColor: [vibrantPalette.blue, vibrantPalette.orange, vibrantPalette.red, vibrantPalette.teal], }]\r\n },\r\n options: { indexAxis: 'y', responsive: true, maintainAspectRatio: false, scales: { x: { beginAtZero: true, title: { display: true, text: 'Number of New Substances' } } }, plugins: { ...tooltipConfig.plugins, legend: { display: false }, tooltip: { ...tooltipConfig.plugins.tooltip, footer: '*Cannabinoid data reflects 2022 reports as a recent high-water mark.' } } }\r\n });\r\n } catch(e) { console.error(\"Error creating npsDiversityChart:\", e); }\r\n };\r\n\r\n \/\/ This robustly waits for the DOM to be ready before trying to create the charts.\r\n if (document.readyState === 'loading') {\r\n document.addEventListener('DOMContentLoaded', initializeDrugInfographicCharts);\r\n } else {\r\n \/\/ DOMContentLoaded has already fired\r\n initializeDrugInfographicCharts();\r\n }\r\n<\/script>\r\n\r\n<\/body>\r\n<\/html>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>La situaci\u00f3n europea de las drogas: Una infograf\u00eda interactiva El panorama europeo de las drogas en evoluci\u00f3n Un an\u00e1lisis de las cifras clave, las amenazas emergentes [...]<\/p>","protected":false},"author":2,"featured_media":3816,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[4,35],"tags":[99,102,101,95,97,61,98,100],"class_list":["post-3813","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-addiction","category-drug-facts","tag-cocaine-trafficking-europe","tag-drug-crisis-europe","tag-drug-policy-eu","tag-drug-free-rehabilitation","tag-european-drug-trends","tag-narconon","tag-synthetic-drugs-europe","tag-youth-addiction-europe"],"acf":[],"yoast_head":"\n<title>Evolving Drug Landscape in Europe: Key Trends<\/title>\n<meta name=\"description\" content=\"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.narconon.online\/es\/evolucion-del-panorama-farmaceutico-europeo\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Europe's Evolving Drug Landscape\" \/>\n<meta property=\"og:description\" content=\"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.narconon.online\/es\/evolucion-del-panorama-farmaceutico-europeo\/\" \/>\n<meta property=\"og:site_name\" content=\"Narconon Europe\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/narcononeu\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-08T18:52:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-07T08:30:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"896\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Jacky Buensoz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NARCONONEurope\" \/>\n<meta name=\"twitter:site\" content=\"@NARCONONEurope\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jacky Buensoz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\"},\"author\":{\"name\":\"Jacky Buensoz\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46\"},\"headline\":\"Europe’s Evolving Drug Landscape\",\"datePublished\":\"2025-06-08T18:52:34+00:00\",\"dateModified\":\"2025-07-07T08:30:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\"},\"wordCount\":792,\"publisher\":{\"@id\":\"https:\/\/www.narconon.online\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"keywords\":[\"Cocaine trafficking Europe\",\"Drug crisis Europe\",\"Drug policy EU\",\"Drug-free rehabilitation\",\"European drug trends\",\"Narconon\",\"Synthetic drugs Europe\",\"Youth addiction Europe\"],\"articleSection\":[\"Addiction\",\"Drug Facts\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\",\"url\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\",\"name\":\"Evolving Drug Landscape in Europe: Key Trends\",\"isPartOf\":{\"@id\":\"https:\/\/www.narconon.online\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"datePublished\":\"2025-06-08T18:52:34+00:00\",\"dateModified\":\"2025-07-07T08:30:27+00:00\",\"description\":\"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage\",\"url\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"contentUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp\",\"width\":1280,\"height\":896,\"caption\":\"Visual representation of the evolving drug landscape in Europe, showing shifting trends and emerging synthetic substances\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.narconon.online\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Europe’s Evolving Drug Landscape\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.narconon.online\/#website\",\"url\":\"https:\/\/www.narconon.online\/\",\"name\":\"Narconon Europe\",\"description\":\"Drug Free For Good\",\"publisher\":{\"@id\":\"https:\/\/www.narconon.online\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.narconon.online\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.narconon.online\/#organization\",\"name\":\"Narconon Europe\",\"url\":\"https:\/\/www.narconon.online\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png\",\"contentUrl\":\"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png\",\"width\":2000,\"height\":707,\"caption\":\"Narconon Europe\"},\"image\":{\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/narcononeu\",\"https:\/\/x.com\/NARCONONEurope\",\"https:\/\/www.instagram.com\/narconon.europe\/\",\"https:\/\/www.youtube.com\/channel\/UCNUxvhoqZZCAxXCYO4K7MvA\",\"https:\/\/www.tiktok.com\/@narconon.europe\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46\",\"name\":\"Jacky Buensoz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.narconon.online\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g\",\"caption\":\"Jacky Buensoz\"},\"description\":\"I have personally experienced various drugs before making the life-changing decision to turn things around. In 1993, I completed the Narconon program in Plans-sur-Bex, Switzerland, a pivotal experience that set me on a new path. Since then, I have dedicated my life to helping and rehabilitating addicts, gaining decades of experience in prevention, rehabilitation, and family support. With years of hands-on experience, I have been serving as the Director of Narconon Europe for the past four years. My mission is to provide effective solutions to help those struggling with addiction and to support their loved ones throughout this transformative journey. My goal is to bring about real change, sharing my expertise and guiding individuals toward a life free from addiction.\"}]}<\/script>\n","yoast_head_json":{"title":"Evoluci\u00f3n del panorama farmac\u00e9utico en Europa: Tendencias clave","description":"Explore la evoluci\u00f3n del panorama farmac\u00e9utico en Europa con datos de 2024 sobre amenazas emergentes y retos para la salud p\u00fablica.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.narconon.online\/es\/evolucion-del-panorama-farmaceutico-europeo\/","og_locale":"es_ES","og_type":"article","og_title":"Europe's Evolving Drug Landscape","og_description":"Explore the evolving drug landscape in Europe with 2024 data on emerging threats and public health challenges.","og_url":"https:\/\/www.narconon.online\/es\/evolucion-del-panorama-farmaceutico-europeo\/","og_site_name":"Narconon Europe","article_publisher":"https:\/\/www.facebook.com\/narcononeu","article_published_time":"2025-06-08T18:52:34+00:00","article_modified_time":"2025-07-07T08:30:27+00:00","og_image":[{"width":1280,"height":896,"url":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","type":"image\/webp"}],"author":"Jacky Buensoz","twitter_card":"summary_large_image","twitter_creator":"@NARCONONEurope","twitter_site":"@NARCONONEurope","twitter_misc":{"Escrito por":"Jacky Buensoz","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#article","isPartOf":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/"},"author":{"name":"Jacky Buensoz","@id":"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46"},"headline":"Europe’s Evolving Drug Landscape","datePublished":"2025-06-08T18:52:34+00:00","dateModified":"2025-07-07T08:30:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/"},"wordCount":792,"publisher":{"@id":"https:\/\/www.narconon.online\/#organization"},"image":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage"},"thumbnailUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","keywords":["Cocaine trafficking Europe","Drug crisis Europe","Drug policy EU","Drug-free rehabilitation","European drug trends","Narconon","Synthetic drugs Europe","Youth addiction Europe"],"articleSection":["Addiction","Drug Facts"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/","url":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/","name":"Evoluci\u00f3n del panorama farmac\u00e9utico en Europa: Tendencias clave","isPartOf":{"@id":"https:\/\/www.narconon.online\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage"},"image":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage"},"thumbnailUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","datePublished":"2025-06-08T18:52:34+00:00","dateModified":"2025-07-07T08:30:27+00:00","description":"Explore la evoluci\u00f3n del panorama farmac\u00e9utico en Europa con datos de 2024 sobre amenazas emergentes y retos para la salud p\u00fablica.","breadcrumb":{"@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#primaryimage","url":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","contentUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/06\/freepik__candid-photography-with-natural-textures-and-highl__49553.webp","width":1280,"height":896,"caption":"Visual representation of the evolving drug landscape in Europe, showing shifting trends and emerging synthetic substances"},{"@type":"BreadcrumbList","@id":"https:\/\/www.narconon.online\/europe-evolving-drug-landscape\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.narconon.online\/"},{"@type":"ListItem","position":2,"name":"Europe’s Evolving Drug Landscape"}]},{"@type":"WebSite","@id":"https:\/\/www.narconon.online\/#website","url":"https:\/\/www.narconon.online\/","name":"Narconon Europa","description":"Libre de drogas para siempre","publisher":{"@id":"https:\/\/www.narconon.online\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.narconon.online\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.narconon.online\/#organization","name":"Narconon Europa","url":"https:\/\/www.narconon.online\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/","url":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png","contentUrl":"https:\/\/www.narconon.online\/wp-content\/uploads\/2025\/03\/Logo-Narconon-Europe-2.png","width":2000,"height":707,"caption":"Narconon Europe"},"image":{"@id":"https:\/\/www.narconon.online\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/narcononeu","https:\/\/x.com\/NARCONONEurope","https:\/\/www.instagram.com\/narconon.europe\/","https:\/\/www.youtube.com\/channel\/UCNUxvhoqZZCAxXCYO4K7MvA","https:\/\/www.tiktok.com\/@narconon.europe"]},{"@type":"Person","@id":"https:\/\/www.narconon.online\/#\/schema\/person\/8fb51aa28a365c0733462afe1f733a46","name":"Jacky Buensoz","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.narconon.online\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/559795e403744d0af7032cd493ad0be9e2d22d91ab576a4fef70d088dd58f71d?s=96&d=mm&r=g","caption":"Jacky Buensoz"},"description":"He experimentado personalmente varias drogas antes de tomar la decisi\u00f3n de cambiar mi vida. En 1993, complet\u00e9 el programa Narconon en Plans-sur-Bex, Suiza, una experiencia crucial que me marc\u00f3 un nuevo camino. Desde entonces, he dedicado mi vida a ayudar y rehabilitar a adictos, adquiriendo d\u00e9cadas de experiencia en prevenci\u00f3n, rehabilitaci\u00f3n y apoyo familiar. Con a\u00f1os de experiencia pr\u00e1ctica, he sido Director de Narconon Europa durante los \u00faltimos cuatro a\u00f1os. Mi misi\u00f3n es proporcionar soluciones eficaces para ayudar a aquellos que luchan contra la adicci\u00f3n y apoyar a sus seres queridos a lo largo de este viaje transformador. Mi objetivo es lograr un cambio real, compartiendo mi experiencia y guiando a las personas hacia una vida libre de adicciones."}]}},"_links":{"self":[{"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/posts\/3813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/comments?post=3813"}],"version-history":[{"count":20,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/posts\/3813\/revisions"}],"predecessor-version":[{"id":3845,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/posts\/3813\/revisions\/3845"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/media\/3816"}],"wp:attachment":[{"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/media?parent=3813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/categories?post=3813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.narconon.online\/es\/wp-json\/wp\/v2\/tags?post=3813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}